Healthbeat - Your Source for Daily Health Trends and Medical News

NIH Workers Risk Retaliation by Openly Protesting Trump Policies

Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.

Adding Menin Inhibitor Promising in Certain AML Patients

(MedPage Today) -- Adding the menin inhibitor revumenib (Revuforj) to azacitidine and venetoclax (Venclexta) seemed to benefit older adults with newly diagnosed NPM1-mutated or KMT2A-rearranged acute

Trump Admin Providing Data on Immigrant Medicaid Enrollees to Deportation Officials

(MedPage Today) -- President Trump's administration this week provided deportation officials with personal data -- including the immigration status -- on millions of Medicaid enrollees, a move th

‘They entrusted me with their daughter’s memory’: Women’s prize winner Rachel Clarke on her story of a life-saving transplant

The Story of a Heart, which won this year’s award for nonfiction, tells how one child saved the life of another.

Anti-Vaxxers on CDC Panel: A Broken Promise From RFK Jr.?

(MedPage Today) -- Despite promising on social media that new vaccine advisors would not be "ideological anti-vaxxers," some of HHS Secretary Robert F. Kennedy Jr.

STAT+: HHS tries pushing pharma to the negotiating table

And more biotech news stories, brought to you by The Readout.

Resident doctors have good reason to strike over pay | Letters

Readers reflect on the hardships faced by younger medics and those training, and the degradation of an entire public serviceI write in response to the letter from senior clinicians urging resident doc

Suman Fernando obituary

My friend and colleague Suman Fernando, who has died aged 92, had an international reputation in the field of critical psychiatry, particularly in relation to advocating for race equity in mental heal

Good News, Mostly, on Preventing Rheumatoid Arthritis

(MedPage Today) -- BARCELONA -- Aggressive treatment for patients who look like they may soon develop rheumatoid arthritis (RA) appears very effective for certain patients, according to long-term d

Two-Drug GVHD Prophylaxis With Cyclophosphamide Prevails for Stem Cell Transplant

(MedPage Today) -- Patients undergoing matched-donor stem cell transplants lived four times longer without episodes of graft-versus-host disease (GVHD) with post-transplant cyclophosphamide-cyclospor

All News